Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: Results of an early phase II clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: Results of an early phase II clinical trial

Published:2008-12 Issue:12 Volume:58 Page:3873-3883
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Muller Sylviane,Monneaux Fanny,Schall Nicolas,Rashkov Rasho K.,Oparanov Boycho A.,Wiesel Philippe,Geiger Jean-Marie,Zimmer Robert

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.24027/fullpdf

Reference24 articles.

1. Systemic lupus erythematosus;D'Cruz;Lancet,2006

2. Challenge in bringing the bench to bedside in drug development for SLE;Merrill;Nat Rev Drug Discov,2004

3. Treatment of systemic lupus erythematosus in 2006;Sibilia;Joint Bone Spine,2006

4. B and T cell immune response to snRNP in lupus mice: autoreactive CD4+ T cells recognize a T cell epitope located within the conserved RNP consensus sequence of the 70K protein;Monneaux;Eur J Immunol,2000

5. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Faslpr and (NZBxNZW)F1 lupus mice;Monneaux;Int Immunol,2001

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibodies against extractable nuclear antigens (RNP, Sm, SS-A/RO, and SS-B/La);Dubois' Lupus Erythematosus and Related Syndromes;2025

2. New and emerging therapies for systemic lupus erythematosus;Clinical Immunology;2024-06

3. Targeting lysosomal quality control as a therapeutic strategy against aging and diseases;Medicinal Research Reviews;2024-05-06

4. Vaccines for immune tolerance against autoimmune disease;Advanced Drug Delivery Reviews;2023-12

5. Peptide-based immunotherapy in lupus: Where are we now?;Rheumatology and Immunology Research;2023-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3